semaglutide
30% Weight Loss Surpasses Semaglutide in MC4R Obesity
30% Weight Loss Surpasses Semaglutide in MC4R Obesity Tirzepatide can produce up to a 30% greater BMI reduction than semaglutide in individuals with MC4R deficiency, offering a more effective option for severe obesity. Early data suggest this advantage translates into better survival and fewer side effects, prompting clinicians to rethink